NCT05705687View on ClinicalTrials.gov

Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

February 28, 2031

Study Completion Date

February 28, 2037

Conditions
Non-Seminomatous Germ Cell Tumor
Interventions
DRUG

BEP Protocol

anticancer therapy

DRUG

Dose-dense regimen

T-BEP-Oxaliplatin followed by Cisplatin - Ifosfamide - Paclitaxel

PROCEDURE

Early tumor resection or HD-CT

TIP protocol + early surgery or high-dose chemotherapy if surgery not feasible or metastatic disease

Trial Locations (1)

94800

RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER